Neutrophil-to-Lymphocyte Ratio (NLR)
The neutrophil-to-lymphocyte ratio (NLR) is a simple calculation dividing your neutrophil count by your lymphocyte count. It captures the balance between innate inflammation and adaptive immunity in a single number, which is why a longevity practice values it as an inexpensive, integrative marker of systemic inflammatory tone.
What It Measures
Ratio of neutrophils to lymphocytes; systemic inflammation and immune balance marker
Optimal vs. Lab Range
Target range for optimal health and longevity based on research.
Population-based reference range from standard labs.
Why It Matters
NLR distills two arms of the immune system into one ratio that reflects overall inflammatory balance. A higher NLR is associated with systemic inflammation and infection, and has been described in the context of cardiovascular risk, cancer risk and poorer prognosis, making it a useful flag when it drifts upward over time. A lower ratio is generally favorable, though an extremely low value could reflect immune suppression. Because it draws on routine blood work already collected, NLR offers an efficient way to monitor inflammatory trends alongside hs-CRP and the underlying neutrophil and lymphocyte counts.
When Low
Generally favorable when low; extremely low may indicate immune suppression
When High
Systemic inflammation, infection, cancer risk, cardiovascular risk, poor prognosis marker
How to Optimize
Improving NLR centers on lowering systemic inflammation and supporting immune balance. Regular exercise, stress management, quality sleep and an anti-inflammatory dietary pattern all help shift the ratio favorably by tempering neutrophil-driven inflammation and supporting lymphocyte health. Treating active infections and addressing chronic inflammatory drivers matters as well. Because a rising or persistently high ratio can reflect a meaningful underlying process, interpret trends with your physician. Targets and treatment are individualized with your physician; this content is educational and not a substitute for medical advice.
Key Interventions & Linked Compounds
Moderate evidenceKey Interventions
Linked Compounds & Supplements
Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.
Ordering Notes
Specimen
Serum or plasma (venous draw)
Patient prep
No fasting required. Maintain usual diet and medications unless advised.
Recommended cadence
Annual
Reporting unit
Confirm with the performing lab — units vary by region.
Pre-analytic notes
Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.
Recommended Follow-Up Actions
- 1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Neutrophil-to-Lymphocyte Ratio (NLR).
- 2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
- 3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
- 4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
- 5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.
Testing Information
Recommended Frequency
Annual
Fasting Requirement
No fasting required
Quick Actions
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
